Evidence map›Paper›PMID 38228894›Full record

Observational studyNeurosurgical review2024

Is the OCT a predictive tool to assess visual impairment in optic chiasm compressing syndrome in pituitary macroadenoma? A prospective longitudinal study.

Maria Teresa Bozzi, Charles-Henry Mallereau, Julien Todeschi, Seyyid Baloglu, François-Daniel Ardellier, Julia Romann, Léa Trouve, Zsolt Bocsksei, Joffrey Alcazar, Guillaume Dannhoff and 4 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Neurosurgical review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Maria Teresa BozziDepartment of Neurosurgery, Bari University Hospital, Bari, Italy.
Charles-Henry MallereauDepartment of Neurosurgery, Strasbourg University Hospital, 1, Av. Moliere, 67098, Strasbourg, France. Mallereau.charles@gmail.com.
Julien TodeschiDepartment of Neurosurgery, Strasbourg University Hospital, 1, Av. Moliere, 67098, Strasbourg, France.
Seyyid BalogluNeuroradiology Unit, Strasbourg University Hospital, Strasbourg, France.
François-Daniel ArdellierNeuroradiology Unit, Strasbourg University Hospital, Strasbourg, France.
Julia RomannDepartment of Ophthalmology, Strasbourg University Hospital, Strasbourg, France.
Léa TrouveDepartment of Ophthalmology, Strasbourg University Hospital, Strasbourg, France.
Zsolt BocskseiDepartment of Ophthalmology, Strasbourg University Hospital, Strasbourg, France.
Joffrey AlcazarDepartment of Ophthalmology, Strasbourg University Hospital, Strasbourg, France.
Guillaume DannhoffDepartment of Neurosurgery, Strasbourg University Hospital, 1, Av. Moliere, 67098, Strasbourg, France.
Thibault BahougneDepartment of Endocrinology, Diabetes and Nutrition, Strasbourg University Hospital, Strasbourg, France.
Bernard GoichotDepartment of Endocrinology, Diabetes and Nutrition, Strasbourg University Hospital, Strasbourg, France.
Salvatore ChibbaroDepartment of Neurosurgery, Strasbourg University Hospital, 1, Av. Moliere, 67098, Strasbourg, France.
Helene CebulaDepartment of Neurosurgery, Strasbourg University Hospital, 1, Av. Moliere, 67098, Strasbourg, France.
Université de Strasbourg · FRUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visual dysfunction is a prevalent symptom in patients with non-functioning pituitary macroadenoma (NFPM); the role of OCT in such patients has not been yet determined. This is a prospective longitudinal observational study over a period of 6 years, on 20 patients presenting a radiological compression of the optic chiasma without visual acuity (VA) and visual field (VF) disturbances. The primary endpoint was to evaluate the impact of NFPA on neuro-axonal loss by measuring RNFL thickness using OCT at inclusion (T0), 12 months (T1), 24 months (T2), and 36 months (T3), respectively. The secondary endpoint was to monitor the evolution of OCT over time and assess any relationship between the degree of OCT alteration and the degree of radiological and clinical optic chiasm compression syndrome. Among the 20 patients included, eight (40%) showed an altered RNFL-OCT at diagnosis, while the remaining 12 (60%) showed a normal pattern. During a mean ophthalmologic follow-up of 60 months, 4 patients (20%) presented an asymptomatic reduction of RNFL-OCT thickness although all 20 had a VA/VF stable. To our knowledge, this study represents the first attempt to longitudinally evaluate the natural history and evolution of RNFL-OCT in patients with radiologically asymptomatic chiasmatic compression syndrome. The results do not clearly demonstrate the role of the OCT as an early prognostic factor for visual dysfunction.

Indexed as

Optic ChiasmPituitary NeoplasmsHumansLongitudinal StudiesProspective StudiesVision DisordersVisual FieldsMacroadenomaOptical coherence tomographyOptic chiasmPituitary adenoma

Identifiers

PMID38228894
OpenAlexW4390928588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.